𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Antisense Cyclin D1 Enhances Sensitivity of Head and Neck Cancer Cells to Cisplatin

✍ Scribed by Marilene B. Wang; Helena T. Yip; Eri S. Srivatsan


Book ID
110082693
Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
715 KB
Volume
111
Category
Article
ISSN
0023-852X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Butyrate response factor 1 enhances cisp
✍ Seung Koo Lee; Seong Bum Kim; Jong Soo Kim; Chang Hoon Moon; Myung Shin Han; Byu πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 French βš– 456 KB πŸ‘ 1 views

Cisplatin is a widely used chemotherapeutic agent in head and neck squamous cell carcinoma (HNSCC). Resistance to cisplatin is a common feature of HNSCC. To identify genes that may regulate cisplatin sensitivity, we carried out a cDNA microarray analysis of gene expression in cisplatin-sensitive and

Inhibition of N-linked glycosylation by
✍ Ichiro Noda; Shigeharu Fujieda; Mizue Seki; Nobuyuki Tanaka; Hiroshi Sunaga; Tos πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 French βš– 155 KB πŸ‘ 2 views

Tunicamycin (TM), a naturally occurring antibiotic, blocks the first step in the biosynthesis of N-linked oligosaccharides in cells. In this study, we investigated whether changes in N-linked glycosylation affect the sensitivity of head-and-neck carcinoma cell lines to cis-diaminedichloroplatinum(II

Intrinsic differences in cisplatin sensi
✍ Cathrine Nilsson; Karin Roberg; Roland C. GrafstrΓΆm; Karin Γ–llinger πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 390 KB πŸ‘ 2 views

## Abstract ## Background Cisplatin treatment is beneficial for approximately 20% of patients with head and neck squamous cell carcinoma (HNSCC). Tools to predict the clinical outcome and evaluate intrinsic cisplatin sensitivity are, therefore, required. ## Methods Cisplatin sensitivity, lysosom